Propellus Stock Price, News & Analysis
Company Description
Propellus (OTC Link: PRPS) is a publicly traded credit services company in the Financial Services sector. The company has a market capitalization of $4.9M.
PRPS stock has gained 525.0% over the past year. Shares last traded at $1.25.
This page provides a comprehensive overview of PRPS stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Propellus (PRPS) stock last traded at $1.25. Over the past 12 months, the stock has gained 525.0%. At a market capitalization of $4.9M, PRPS is classified as a micro-cap stock with approximately 9.0M shares outstanding.
Latest News
Propellus has 7 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 0 with negative movement. Key topics include dividends, earnings. View all PRPS news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Propellus (PRPS) currently stands at 1 shares, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 99.9%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Propellus (PRPS) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 37.7 days.
PRPS Company Profile & Sector Positioning
Propellus (PRPS) operates in the Credit Services industry within the broader Financial Services sector and is listed on the OTC Link.
Investors comparing PRPS often look at related companies in the same sector, including STANDARD PREMIUM FINANCE HOLDI (SPFX), Fincanna Capital (FNNZF), Jianpu Technolog (AIJTY), Dinewise (DWIS), and Cv Holdings (CVHL). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate PRPS's relative position within its industry.